In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.

MK-0366, a new derivative of nalidixic acid, was tested against 250 urinary pathogens including Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa. This new agent was more active than any of the other antibiotics tested, which included carbenicillin, ampicillin, cephalexin, tetracycli...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Downs, J, Andriole, V T, Ryan, J L
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1982
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181965/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6211142/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.4.670
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!